Sexual Health & Medical Wellness Artificial Intelligence Is Giving Researchers a New Way to Listen to What Patients Are Saying About Popular GLP-1 Drugs September 13, 2026 Susilo Ahmad The rapid ascent of glucagon-like peptide-1 (GLP-1) receptor agonists—a class of medications including semaglutide (marketed as Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound)—has fundamentally altered the landscape of…
